This episode defines pharmacovigilance and explains its critical role in monitoring drug safety after a medication has been approved and is on the market. We delve into the core activities of pharmacovigilance, which include adverse event detection, assessment, understanding, and prevention. The conversation highlights the ongoing nature of safety monitoring, emphasizing that it doesn't end with a drug's approval.
Real-world case examples are used to illustrate how potential safety concerns are identified and managed. The discussion covers the difference between observations in clinical trials and real world environments. We discuss the interactions between different medicines, with food, and explore how they might be different depending on the individual.
Fler avsnitt av From Concept to Medicine - A Comprehensive Drug Development Journey
Visa alla avsnitt av From Concept to Medicine - A Comprehensive Drug Development JourneyFrom Concept to Medicine - A Comprehensive Drug Development Journey med Jim Mitchell finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
